Sure Rubicon may be ahead of the curve due to first mover...

Sure Rubicon may be ahead of the curve due to first mover advantage or marketing however keep in mind the folowing:

1) RHS now boasts one of the most accurate products in this business
2) RHS has a product with the shortest protocol time in this market:





3) RHS will be ramping up marketing activities as evidenced by the following:
*Recently appointed US based business development executive and a European based global marketing consultant to assist with marketting strategy.
*The company continues to hold commercial discussions with overseas and national clinical groups on the establishment of preimplantation genetic screening services.

4) RHS has a complete Next Generation Sequencing solution for Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening, from Whole Genome Amplification through library preparation to bioinformatics and reporting. This makes it really easy to market their products and would put them on the radar of the larger biomed companies....wouldn't be surprised with RHS eventually being taken over/merged into a larger company down the line....

5) Management have said that there will be alot more news to come, its all just getting started imo

Hope everyone is enjoying Easter, see you guys at 40c next week